drugset / Trial / NCT00004585
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
Treatment
Summary
The purpose of this study is to see if a certain combination of anti-HIV drugs is safe and effective in HIV-infected patients. The drug combination includes a tablet containing lamivudine and zidovudine (called Combivir) plus abacavir plus efavirenz.
Timeline
- Start
- 1999-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir | Other / unclassified | 300 mg | — |
| Subject | Efavirenz | Other / unclassified | 600 mg | — |
| Subject | Lamivudine | Other / unclassified | 150 mg | — |
| Subject | Zidovudine | Small molecule | 300 mg | — |